Worrying that your startup will be eaten by the model companies is like worrying that your life will be constrained after you become a movie star. You're far more likely simply to fail.
Actually, your analysis might fail regardless of which you picked. But one thing is for sure: your analysis will be very different depending on the choice. https://t.co/cFgkAPGIm7
Today we report single-cell APEX-seq (scAPEX-seq) — a new method for unbiased mapping of *subcellular* transcriptomes at single-cell resolution. This approach reveals cell states that are not detectable by standard scRNA-seq, and enabled us to identify regulators of CAR T function that improve solid tumor killing.
https://t.co/iAJUj6jBQ4
Ambient RNA & barcode swapping is a serious issue in single-cell genomics. Tools such as CellBender, scAR, DecontX & SoupX. We have developed CellSweep which is faster (in some cases by a lot) and much more accurate. Extensively tested and benchmarked. https://t.co/7ZRjDuJocP 1/
Anyone who understands biomedical and clinical research knows that AI won't magically compress a century of medical progress into 5–10 years.
The bottleneck of research is in doing experiments and clinical trials.
We need to be guided by serious science, not hype.
@KayLMurray@ESPNFC Ale, missed your perspective yesterday in the panel on the referee-real Madrid saga... how out of line Real Madrid's approaches were?
Real Madrid are becoming a joke.
All the accusations in the world won’t hide the fact that they simply haven’t been good enough this season. Already they are putting excuses in place if again they fall short against Barcelona.
This week, we are excited to host guests from all over the world to experience the new Bangladesh: the youth, the resilience, the warmth, and the story of our generational moonshot.
#InvestBangladesh